Index S&P 500
P/E 42.67
EPS (ttm) 20.22
Insider Own 10.21%
Shs Outstand 945.84M
Perf Week 4.53%
Market Cap 815.73B
Forward P/E 28.01
EPS next Y 30.80
Insider Trans -1.51%
Shs Float 848.86M
Perf Month 5.25%
Enterprise Value 848.38B
PEG 1.01
EPS next Q 7.02
Inst Own 73.84%
Short Float 0.81%
Perf Quarter 12.21%
Income 18.41B
P/S 13.73
EPS this Y 78.26%
Inst Trans -0.45%
Short Ratio 1.52
Perf Half Y 4.76%
Sales 59.42B
P/B 34.30
EPS next Y 33.01%
ROA 19.33%
Short Interest 6.84M
Perf YTD 11.77%
Book/sh 25.16
P/C 82.29
EPS next 5Y 42.09%
ROE 96.82%
52W High 935.62 -7.78%
Perf Year -4.51%
Cash/sh 10.49
P/FCF 87.98
EPS past 3/5Y 24.14% 18.77%
ROIC 28.47%
52W Low 623.78 38.33%
Perf 3Y 141.12%
Dividend Est. 5.86 (0.68%)
EV/EBITDA 29.99
Sales past 3/5Y 16.73% 15.08%
Gross Margin 83.03%
Volatility 3.12% 2.52%
Perf 5Y 508.93%
Dividend TTM 5.80 (0.67%)
EV/Sales 14.28
EPS Y/Y TTM 88.21%
Oper. Margin 44.41%
ATR (14) 22.55
Perf 10Y 1001.85%
Dividend Ex-Date Nov 14, 2025
Quick Ratio 1.24
Sales Y/Y TTM 45.41%
Profit Margin 30.99%
RSI (14) 66.72
Recom 1.58
Dividend Gr. 3/5Y 15.21% 15.05%
Current Ratio 1.55
EPS Q/Q 479.29%
SMA20 4.34%
Beta 0.42
Target Price 946.33
Payout 44.39%
Debt/Eq 1.79
Sales Q/Q 53.87%
SMA50 10.55%
Rel Volume 1.11
Prev Close 844.50
Employees 47000
LT Debt/Eq 1.72
Earnings Oct 30 BMO
SMA200 9.38%
Avg Volume 4.51M
Price 862.86
IPO Jul 09, 1970
Option/Short Yes / Yes
EPS/Sales Surpr. 23.33% 9.64%
Trades
Volume 5,009,494
Change 2.17%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-20-25 Reiterated
BMO Capital Markets
Outperform
$840 → $930
Oct-14-25 Upgrade
Erste Group
Hold → Buy
Sep-17-25 Downgrade
Berenberg
Buy → Hold
$830
Aug-27-25 Upgrade
HSBC Securities
Reduce → Hold
$700
Aug-18-25 Downgrade
Daiwa Securities
Outperform → Neutral
$700
Aug-07-25 Downgrade
Leerink Partners
Outperform → Market Perform
$715
Jun-05-25 Downgrade
Erste Group
Buy → Hold
Apr-28-25 Downgrade
HSBC Securities
Buy → Reduce
$1150 → $700
Apr-22-25 Initiated
Cantor Fitzgerald
Overweight
$975
Dec-10-24 Resumed
BofA Securities
Buy
$997
Nov-15-24 Initiated
Wolfe Research
Outperform
$1000
Oct-17-24 Initiated
Bernstein
Outperform
$1100
Sep-13-24 Resumed
Citigroup
Buy
$1060
Aug-12-24 Upgrade
Deutsche Bank
Hold → Buy
$1025
Feb-21-24 Downgrade
DZ Bank
Buy → Hold
$820
Feb-16-24 Reiterated
Morgan Stanley
Overweight
$805 → $950
Dec-21-23 Downgrade
Daiwa Securities
Buy → Outperform
$660 → $610
Nov-09-23 Initiated
Deutsche Bank
Hold
$535
Oct-20-23 Resumed
UBS
Buy
$612 → $710
Aug-09-23 Upgrade
Jefferies
Hold → Buy
$408 → $615
Show Previous Ratings
Nov-01-25 03:29PM
08:05AM
(Investor's Business Daily)
07:57AM
(Investor's Business Daily)
07:00AM
Oct-31-25 06:00PM
(The Wall Street Journal)
05:54PM
Loading…
05:54PM
(Investor's Business Daily)
05:30PM
05:12PM
01:38PM
12:30PM
11:04AM
10:28AM
09:42AM
08:03AM
(Pharmaceutical Technology)
07:50AM
07:09AM
Loading…
07:09AM
(The Wall Street Journal)
02:45AM
01:30AM
Oct-30-25 09:05PM
07:53PM
07:53PM
06:53PM
06:00PM
(The Wall Street Journal)
05:23PM
(The Wall Street Journal)
04:52PM
(Investor's Business Daily)
04:41PM
04:41PM
04:35PM
(The Wall Street Journal)
04:15PM
(Investor's Business Daily)
04:09PM
(Investor's Business Daily)
03:46PM
Loading…
03:46PM
(Investor's Business Daily)
02:30PM
02:11PM
01:50PM
01:31PM
01:10PM
12:57PM
12:12PM
11:10AM
10:51AM
10:41AM
(The Wall Street Journal)
10:39AM
(Associated Press Finance)
10:38AM
10:30AM
10:25AM
10:08AM
09:36AM
09:25AM
09:22AM
09:09AM
08:34AM
08:28AM
08:25AM
(Investor's Business Daily)
08:20AM
08:19AM
08:09AM
07:57AM
(The Wall Street Journal)
07:55AM
07:51AM
(Pharmaceutical Technology)
07:22AM
07:20AM
(The Wall Street Journal)
07:11AM
07:04AM
06:53AM
(Associated Press Finance)
06:45AM
06:32AM
(Pharmaceutical Technology)
06:31AM
05:47AM
(The Wall Street Journal)
05:20AM
(The Wall Street Journal)
05:08AM
04:29AM
Oct-29-25 07:00PM
04:45PM
04:33PM
04:15PM
(The Wall Street Journal)
02:51PM
02:25PM
(Pharmaceutical Technology)
11:52AM
11:40AM
10:30AM
09:31AM
08:22AM
08:11AM
07:00AM
06:20AM
04:40AM
04:10AM
(The Wall Street Journal)
04:00AM
Oct-28-25 11:22PM
10:31PM
08:10PM
06:54PM
06:54PM
05:56PM
05:01PM
04:42PM
(The Wall Street Journal)
04:23PM
04:11PM
(The Wall Street Journal)
04:04PM
02:31PM
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LILLY ENDOWMENT INC 10% Owner Oct 10 '25 Sale 863.24 3,658 3,157,722 94,533,320 Oct 14 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 09 '25 Sale 852.49 10,602 9,038,055 94,536,978 Oct 10 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 10 '25 Proposed Sale 855.35 305,000 260,881,750 Oct 10 02:57 PM LILLY ENDOWMENT INC 10% Owner Oct 08 '25 Sale 850.27 101,420 86,234,874 94,547,580 Oct 09 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 07 '25 Sale 848.01 26,795 22,722,401 94,649,000 Oct 08 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 06 '25 Sale 850.22 161,183 137,041,657 94,675,795 Oct 07 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 03 '25 Sale 837.93 192,404 161,220,401 94,836,978 Oct 06 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 06 '25 Proposed Sale 839.87 300,000 251,961,000 Oct 06 03:35 PM LILLY ENDOWMENT INC 10% Owner Oct 02 '25 Sale 821.55 112,596 92,503,361 95,029,382 Oct 03 04:00 PM LILLY ENDOWMENT INC 10% Owner Oct 01 '25 Sale 821.47 215,822 177,290,448 95,141,978 Oct 02 04:56 PM LILLY ENDOWMENT INC 10% Owner Oct 01 '25 Sale 794.15 135,193 107,363,016 95,357,800 Oct 02 04:55 PM LILLY ENDOWMENT INC 10% Owner Oct 02 '25 Proposed Sale 825.42 305,000 251,753,100 Oct 02 03:20 PM LILLY ENDOWMENT INC 10% Owner Oct 01 '25 Proposed Sale 763.00 295,000 225,085,000 Oct 01 04:08 PM LILLY ENDOWMENT INC 10% Owner Sep 30 '25 Sale 763.39 113,694 86,793,274 95,492,993 Oct 01 04:00 PM LILLY ENDOWMENT INC 10% Owner Sep 19 '25 Sale 763.10 23,665 18,058,643 95,606,687 Sep 22 04:00 PM LILLY ENDOWMENT INC 10% Owner Sep 18 '25 Sale 764.65 106,626 81,531,959 95,630,352 Sep 19 04:00 PM LILLY ENDOWMENT INC 10% Owner Sep 18 '25 Proposed Sale 760.13 300,000 228,039,000 Sep 18 03:04 PM DONALD ZAKROWSKI Officer Aug 28 '25 Proposed Sale 734.17 2,000 1,468,340 Aug 28 04:19 PM Zakrowski Donald A SVP, Finance, & CAO Aug 28 '25 Sale 734.93 1,000 734,930 3,840 Aug 28 04:14 PM Montarce Lucas EVP & CFO Aug 15 '25 Buy 691.79 715 494,627 14,685 Aug 15 04:13 PM Alvarez Ralph Director Aug 13 '25 Buy 660.25 758 500,473 758 Aug 14 04:12 PM Van Naarden Jacob EVP & Pres., Lilly Oncology Aug 13 '25 Buy 647.36 1,000 647,360 20,562 Aug 13 04:15 PM Ricks David A President, Chair, and CEO Aug 12 '25 Buy 644.77 1,632 1,052,263 546,601 Aug 12 04:23 PM Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm Aug 12 '25 Buy 634.40 1,000 634,405 137,660 Aug 12 04:20 PM Sulzberger Gabrielle Director Aug 12 '25 Buy 641.18 117 75,018 2,703 Aug 12 04:19 PM Fyrwald J Erik Director Aug 12 '25 Buy 642.33 1,565 1,005,242 74,578 Aug 12 04:17 PM Yuffa Ilya EVP&Pres, LLY USA&Global Capab Aug 11 '25 Sale 627.01 1,250 783,762 26,260 Aug 12 04:16 PM JACKSON JAMERE Director Aug 08 '25 Buy 639.56 200 127,913 9,402 Aug 08 04:20 PM Seymour Melissa EVP, Global Quality Aug 01 '25 Option Exercise 0.00 952 0 952 Aug 04 04:16 PM LILLY ENDOWMENT INC 10% Owner Jul 24 '25 Sale 805.07 280,000 225,419,259 95,736,978 Jul 25 04:00 PM LILLY ENDOWMENT INC 10% Owner Jul 24 '25 Proposed Sale 798.89 280,000 223,689,200 Jul 24 03:01 PM Zakrowski Donald A SVP, Finance, & CAO May 27 '25 Sale 716.41 1,000 716,410 4,840 May 27 04:13 PM Yuffa Ilya EVP & President, LLY Int'l May 14 '25 Sale 749.24 1,250 936,550 27,510 May 15 04:17 PM Yuffa Ilya Officer May 14 '25 Proposed Sale 749.24 2,500 1,873,100 May 14 12:25 PM DONALD ZAKROWSKI Officer Mar 13 '25 Proposed Sale 821.86 2,000 1,643,720 Mar 13 04:57 PM Zakrowski Donald A SVP, Finance, & CAO Mar 13 '25 Sale 818.24 1,000 818,240 5,840 Mar 13 04:17 PM LILLY ENDOWMENT INC 10% Owner Mar 03 '25 Sale 928.76 220,000 204,326,151 96,016,978 Mar 04 04:00 PM Dozier Eric EVP, Chief People Officer Mar 01 '25 Option Exercise 0.00 2,403 0 10,905 Mar 03 04:53 PM Hernandez Edgardo EVP & Pres., Mfg. Operations Mar 01 '25 Option Exercise 0.00 2,837 0 41,009 Mar 03 04:51 PM LILLY ENDOWMENT INC 10% Owner Mar 03 '25 Proposed Sale 920.63 220,000 202,538,600 Mar 03 03:34 PM LILLY ENDOWMENT INC 10% Owner Feb 25 '25 Sale 903.07 225,000 203,190,794 96,236,978 Feb 26 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 24 '25 Sale 883.97 60,432 53,419,955 96,461,978 Feb 25 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 25 '25 Proposed Sale 881.40 225,000 198,315,000 Feb 25 03:05 PM LILLY ENDOWMENT INC 10% Owner Feb 21 '25 Sale 882.70 99,452 87,786,505 96,522,410 Feb 24 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 20 '25 Sale 877.99 14,685 12,893,353 96,621,862 Feb 21 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 19 '25 Sale 878.45 9,985 8,771,285 96,636,547 Feb 20 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 13 '25 Sale 879.52 35,446 31,175,396 96,646,532 Feb 14 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 13 '25 Proposed Sale 872.97 220,000 192,053,400 Feb 13 03:43 PM Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm Feb 10 '25 Sale 863.21 5,000 4,316,065 117,888 Feb 12 04:15 PM Skovronsky Daniel Officer Feb 10 '25 Proposed Sale 863.19 5,000 4,315,954 Feb 10 11:44 AM LILLY ENDOWMENT INC 10% Owner Feb 06 '25 Sale 874.13 210,000 183,567,262 96,681,978 Feb 07 04:00 PM LILLY ENDOWMENT INC 10% Owner Feb 06 '25 Proposed Sale 842.18 210,000 176,857,800 Feb 06 04:04 PM Yuffa Ilya EVP & President, LLY Int'l Feb 01 '25 Option Exercise 0.00 3,269 0 23,071 Feb 04 04:28 PM White Anne E. EVP & Pres, Lilly Neuroscience Feb 01 '25 Option Exercise 0.00 3,269 0 68,838 Feb 04 04:27 PM Van Naarden Jacob EVP & Pres., Lilly Oncology Feb 01 '25 Option Exercise 0.00 3,023 0 14,868 Feb 04 04:26 PM Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm Feb 01 '25 Option Exercise 0.00 8,989 0 126,892 Feb 04 04:25 PM Ricks David A President, Chair, and CEO Feb 01 '25 Option Exercise 0.00 26,561 0 496,385 Feb 04 04:24 PM Rau Diogo EVP & CIDO Feb 01 '25 Option Exercise 0.00 3,269 0 14,370 Feb 04 04:23 PM Jonsson Patrik EVP&Pres, CardMetHlth, LLY USA Feb 01 '25 Option Exercise 0.00 3,433 0 48,016 Feb 04 04:23 PM Hernandez Edgardo EVP & Pres., Mfg. Operations Feb 01 '25 Option Exercise 0.00 2,861 0 33,479 Feb 04 04:21 PM Hakim Anat EVP, GC & Secretary Feb 01 '25 Option Exercise 0.00 4,904 0 20,683 Feb 04 04:19 PM Zakrowski Donald A Officer Nov 08 '24 Proposed Sale 803.38 900 723,042 Nov 08 04:54 PM Zakrowski Donald A SVP, Finance, & CAO Nov 08 '24 Sale 803.38 900 723,042 5,480 Nov 08 04:18 PM